After Long Decline, Industry Spending On CME Programs Rises Again
This article was originally published in The Gray Sheet
Executive Summary
Drug and device companies increased funding for continuing medical education programs by 2.4 percent in 2014 to $675.9 million; support had declined steadily since peaking in 2007.